# Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas

> **NCT04869449** · EARLY_PHASE1 · TERMINATED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Glioblastoma
- Glioblastoma Multiforme
- Glioblastoma Multiforme of Brain
- Glioblastoma Multiforme, Adult

## Interventions

- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT04869449
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-11
- **Primary completion:** 2022-05-12
- **Final completion:** 2022-05-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Enrollment was stopped due to direction from the scientific review committee of the Penn State Cancer Institute. The instruction came due to slow accrual.
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04869449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04869449, "Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04869449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*